TELESCOPE, Remote Decision Coaching with Navigation Intervention for Lung Cancer
Rutgers, Cancer Institute of New Jersey, New Brunswick, NJ
TELESCOPE, Remote Decision Coaching with Navigation InterventionN/ARecruitingLed by Anita Y Kinney, PhDResearch Sponsored by Rutgers, The State University of New JerseyEligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be a current or former smoker having quit within the past 15 years
Have at least a 20 pack-year smoking history
Must not have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Upthe change in baseline, three months and five years
Awards & highlights
No Placebo-Only Group
Study Summary
This trial is testing whether navigator decision coaching, compared to enhanced usual care, results in better decision making for lung cancer screening, more screenings, and increased adherence to repeat screenings and diagnostic testing. A booster coaching session is also being tested to see if it increases adherence to repeat screenings.
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowSelect...
You have smoked cigarettes either currently or in the past, and have quit within the last 15 years.
Select...
You have smoked at least one pack of cigarettes a day for 20 years.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ the change in baseline, three months and five years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the change in baseline, three months and five years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
To assess shared decision making
Secondary outcome measures
Tobacco treatment referral
Other outcome measures
Completion of diagnostic testing
Receipt of tobacco treatment
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: TELESCOPE interventionExperimental Treatment1 Intervention
Participants will be surveyed at baseline and at one-week after the scheduled primary care office visit. If a participant is a current smoker then they are offered and navigated to evidence-based smoking cessation. If the participant is interested in screening, an LDCT is ordered. Support for screening, diagnostic testing and oncology care will be provided as needed from the Nurse Navigators.
Group II: Enhanced usual care (EUC)Active Control1 Intervention
Participants will be surveyed at baseline and at one-week after the scheduled primary care office visit. Primary and secondary outcome data related to the office visit will be collected.
Find a site
Who is running the clinical trial?
Rutgers, The State University of New JerseyLead Sponsor
402 Previous Clinical Trials
60,270 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,595 Previous Clinical Trials
6,796,411 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,713 Previous Clinical Trials
47,168,529 Total Patients Enrolled
Anita Y Kinney, PhDPrincipal Investigator
Rutgers Cancer Institute of New JerseyAnita Y Kinney, PhD, RNPrincipal Investigator
Rutgers Cancer Institute of New Jersey3 Previous Clinical Trials
487 Total Patients Enrolled
Media Library
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research endeavor actively recruiting participants?
"According to information hosted on clinicaltrials.gov, this specific medical trial is not currently enrolling patients. The study was first posted on February 28th 2023 and the last update occured October 31st 2022. Despite this, there are still 1496 active trials searching for participants at present."
Answered by AI